Benzinga | Aug 5, 2021 04:32PM EDT

Celldex Therapeutics Q2 EPS $(0.34) Up From $(0.50) YoY, Sales $3.48M Up From $236.00K YoY

Celldex Therapeutics (NASDAQ:CLDX) reported quarterly losses of $(0.34) per share. This is a 32 percent increase over losses of $(0.50) per share from the same period last year. The company reported $3.48 million in sales this quarter. This is a 1.37K percent increase over sales of $236.00 thousand the same period last year.